{"id":"W7117568319","doi":"10.2967/jnumed.125.270814","title":"BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of <sup>225</sup> Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Nuclear Medicine","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Hepatocellular carcinoma; Limiting; Cancer; Glypican 3; Disease; Carcinoma; Clinical trial; Sorafenib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002311284,0.002321396,0.002123363,0.0007312616,0.0007422977,0.001286745,0.00153539,0.00167109,0.003153687],"category_scores_gemma":[0.00107776,0.0008339154,0.001124422,0.0005181496,0.001538404,0.001362125,0.0005350449,0.005040019,0.001285256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00126712,"about_ca_system_score_gemma":0.002318348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001329497,"about_ca_topic_score_gemma":0.002531359,"domain_scores_codex":[0.9990815,0.0004519482,0.00003623747,0.0001373418,0.0001015766,0.00019142],"domain_scores_gemma":[0.9988958,0.0001348881,0.0001784835,0.0001457601,0.00008224217,0.0005627655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3622682,0.3324672,0.006170614,0.0008165467,0.001050793,0.0004999341,0.0006339323,0.00501758,0.1787663,0.0006005787,0.01074316,0.1009652],"study_design_scores_gemma":[0.2545547,0.713814,0.007835608,0.0000266508,0.0002740083,0.0004358721,0.0001311288,0.001700288,0.01581446,0.0003047943,0.005047743,0.0000607727],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896178,0.001133828,0.001334164,0.0007506743,0.0002059641,0.003604734,0.001099978,0.0002696458,0.001983267],"genre_scores_gemma":[0.9790106,0.001407627,0.004475947,0.001625456,0.0002474324,0.005267188,0.003168598,0.0001286634,0.0046685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003153687,"threshold_uncertainty_score":0.01222342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03728831012525907,"score_gpt":0.2997761535208324,"score_spread":0.2624878433955734,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}